This idea is further supported by evidence concerning the role of thyroid hormone in CRC progression, with studies concluding that it limits tumor growth through differentiation (Cicatiello et al., 2017), whereas others report that it enhances tumor growth through repression of Wnt inhibitors (Uchuya-Castillo et al., 2018). This evidence concerns the gene TG and colorectal carcinoma.